Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer

Mar 13, 2017 by in ONCOLOGY Comments Off on Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer

Target Agent(s) Phase Summary Identifier mTOR Everolimus (Docetaxel) (Bevacizumab) Ib/II Dose-finding/efficacy study; Docetaxel + everolimus + bevacizumab in metastatic CRPC NCT00574769 mTOR Temsirolimus (Bevacizumab) I/II Dose-finding/efficacy study; Temsirolimus + bevacizumab in metastatic CRPC NCT01083368 mTOR Everolimus…

read more

Genetic Counseling

Mar 13, 2017 by in ONCOLOGY Comments Off on Genetic Counseling

Question 7.1 The family depicted has Lynch syndrome (previously referred to as the hereditary nonpolyposis colon cancer [HNPCC]) syndrome. This syndrome is characterized by a high risk to develop colon…

read more

Oncologic Emergencies

Mar 13, 2017 by in ONCOLOGY Comments Off on Oncologic Emergencies

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 34 Oncologic Emergencies Preet Paul Singh QUESTIONS Each of the numbered items below is followed by lettered answers. Select the ONE lettered answer…

read more

Stem Cell Transplantation

Mar 13, 2017 by in ONCOLOGY Comments Off on Stem Cell Transplantation

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 33 Stem Cell Transplantation Brian Hess and Rizwan Romee QUESTIONS Each of the numbered items below is followed by lettered answers. Select the…

read more

Plasma Cell Neoplasms

Mar 13, 2017 by in ONCOLOGY Comments Off on Plasma Cell Neoplasms

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 31 Plasma Cell Neoplasms Ravi Vij and Jesse Keller QUESTIONS Each of the numbered items below is followed by lettered answers. Select the…

read more

Immunosuppression-Related Malignancies

Mar 13, 2017 by in ONCOLOGY Comments Off on Immunosuppression-Related Malignancies

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 32 Immunosuppression-Related Malignancies Lee Ratner QUESTIONS Each of the numbered items below is followed by lettered answers. Select the ONE lettered answer that…

read more

Chronic Leukemias

Mar 13, 2017 by in ONCOLOGY Comments Off on Chronic Leukemias

One of the most prognostically significant landmarks is achieving CCyR at 12 months and many other parameters are based on the likelihood of obtaining this response. For example, for patients…

read more

Acute Leukemias

Mar 13, 2017 by in ONCOLOGY Comments Off on Acute Leukemias

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 29 Acute Leukemias Amanda F. Cashen QUESTIONS Each of the numbered items below is followed by lettered answers. Select the ONE lettered answer…

read more

Lymphomas

Mar 13, 2017 by in ONCOLOGY Comments Off on Lymphomas

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 28 Lymphomas Nina Wagner-Johnston and Dilan Patel QUESTIONS Each of the numbered items below is followed by lettered answers. Select the ONE lettered…

read more

Cancer of the Skin and Melanoma

Mar 13, 2017 by in ONCOLOGY Comments Off on Cancer of the Skin and Melanoma

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 27 Cancer of the Skin and Melanoma Gerald P. Linette QUESTIONS Each of the numbered items below is followed by lettered answers. Select…

read more
Get Clinical Tree app for offline access